SPOTLIGHT: Sonic buys Bioscientia


Bioscientia, one of the largest diagnostics companies in Germany, has been acquired by Sonic Healthcare, which valued the company at €190 million. BioScientia operates 15 regional labs in Germany and other hospital-based facilities. The company was spun off by Ingelheim in 1995. Sonic Healthcare says the deal greatly enhances the company's global reach. Report

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.